Search

SYROS CRUSHED AS LEAD DRUG IS FAILING ITS PHASE II TRIAL BADLY

The ongoing trial of SY-1425 is assessing the safety and efficacy as both a single agent and a combination agent in AML and MDS patients...

 
 
 

ANTI-MONEY LAUNDERING / BSA ANALYST

RESPONSIBILITIES: Kforce has a client that is searching for an AML/BSA Analyst in Charlotte, NC. Duties: Responsible for fulfilling...

AGIOS RELEASE: NEW DATA FROM PHASE I/II TRIAL OF ORAL IDHIFA DEMONSTRATE DURABLE COMPLETE RESPONSES IN PATIENTS WITH IDH2 MUTANT RELAPSED OR REFRACTORY AML

Life Sciences Jobs ...

 
 
 

MICROSTRATEGY DEVELOPER

Microstrategy a MUST The position is within the AML Big Data development team. This role will require the candidate to Lead Microstrategy...

BMS, INNATE CHECKPOINT INHIBITOR FLUNKS AML PHASE 2

BMS, Innate checkpoint inhibitor flunks AML phase 2 nick.paul.taylor Mon, 02/06/2017 - 03:24

 
 
 
Fatalities put Seattle Genetics' trials on hold

FATALITIES PUT SEATTLE GENETICS' TRIALS ON HOLD

Three out of five clinical trials evaluating Seattle Genetics' investigational ADC vadastuximab have ground to a halt after six adverse...

4 FATAL DEATHS IN SEATTLE GENETICS' EARLY-STAGE TRIALS OF AML DRUG

Life Sciences Jobs ...

 
 
 

ACTINIUM TO SPONSOR UPCOMING BLOOD & MARROW TRANSPLANT INFORMATION NETWORK WEBINAR FOCUSED ON STEM CELL TRANSPLANTS FOR PATIENTS WITH AML

Life Sciences Jobs ...